fda glp-1 news november 2025 Lilly is now pharma's top revenue company. It just got approval for an oral GLP-1, but Wall Street isn't celebrating FDA approval for Zepbound (tirzepatide)

It is a once-weekly injectable medication that works alongside nutrition and physical activity guidance

RTD product penetration increased from 13.2% to 21.6% between 2024 to 2029

The GLP-1 obesity home delivery injectables market is shaped by molecule preference and patient treatment profiles

This hormone responds to food intake and plays a critical role in regulating blood sugar levels by stimulating insulin secretion and reducing the production of glucagon, another hormone that raises blood sugar

Microdosing GLP-1s means taking a dose that is even lower than the lowest FDA-approved dose for a particular weight-loss medication, says Dr